Macquarie Group
ATRA icon

Macquarie Group’s Atara Biotherapeutics ATRA Stock Holding History

Macquarie Group’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-197
Closed -$1.68K – 1671
2024
Q2 		$1.68K Buy
+197
New +$2.96K ﹤0.01% 1815
2022
Q3 		– Sell
-26
Closed -$2.92K – 2493
2022
Q2 		$5K Hold
26
– – ﹤0.01% 2518
2022
Q1 		$6 Hold
26
– – ﹤0.01% 2567
2021
Q4 		$10K Sell
26
-106
-80% -$44.6K ﹤0.01% 2506
2021
Q3 		$59K Buy
132
+101
+326% +$36.2K ﹤0.01% 2176
2021
Q2 		$12K Hold
31
– – ﹤0.01% 2450
2021
Q1 		$11K Sell
31
-15
-33% -$6.63K ﹤0.01% 2376
2020
Q4 		$22K Hold
46
– – ﹤0.01% 2203
2020
Q3 		$15K Hold
46
– – ﹤0.01% 2216
2020
Q2 		$17K Buy
+46
New +$11.6K ﹤0.01% 2209
2018
Q3 		– Sell
-76
Closed -$70K – 2155
2018
Q2 		$70K Buy
+76
New +$81.6K ﹤0.01% 1907

Other funds holding ATRA

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return